Industrial conglomerate 3M Co said on Thursday it would sell its drug delivery business to investment firm Altaris Capital Partners LLC for about $650 million as part of its plan to shed non-core assets. The company said it would retain its transdermal drug delivery components business. “This transaction will allow us to focus more resources on our core health care business as well as retain a share in the value of the drug delivery business as it grows over the coming years” Chief Executive Officer Michael Roman said. …read more
Source:: Yahoo Finance
